Arcutis Biotherapeutics, Inc.ARQTNASDAQ
Loading
Gross Margin Over TimeStrong
Percentile Rank71
3Y CAGR+4.3%
Studio
Year-over-Year Change

Gross profit as a percentage of revenue

3Y CAGR
+4.3%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM90.24%-0.0%
202490.27%-1.5%
202391.63%+15.2%
202279.54%-
20200.00%-
20190.00%-
20180.00%-
20170.00%-